Bank Of Nova Scotia Horizon Therapeutics Public LTD CO Transaction History

Bank Of Nova Scotia

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $23.3 Million - $27.3 Million	-235,491 Reduced 44.22%	297,009 $34.4 Million
Q2 2023 Aug 03, 2023	SELL	$96.34 - $112.38 $35.6 Million - $41.6 Million	-369,810 Reduced 40.98%	532,500 $54.8 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $73.4 Million - $77.7 Million	684,167 Added 313.63%	902,310 $98.5 Million
Q4 2022 Feb 09, 2023	SELL	$62.39 - $113.8 $86.1 Million - $157 Million	-1,380,115 Reduced 86.35%	218,143 $24.8 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $64.4 Million - $92.5 Million	1,092,981 Added 216.31%	1,598,258 $98.9 Million

Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $40.1 Million - $58.8 Million	505,277 New	505,277 $40.3 Million
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $30.3 Million - $44.4 Million	-381,201 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$86.42 - $109.81 $13.5 Million - $17.2 Million	156,663 Added 69.77%	381,201 $40.1 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $12.6 Million - $15.3 Million	127,484 Added 131.35%	224,538 $24.2 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $8.92 Million - $10.7 Million	97,054 New	97,054 $10.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.